RxDoctor Payments Data

Rajiv Chhabra, MD

Gastroenterology · Kansas City, MONPI 1841393196

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,500 of the $28,543 with a category attached, or 71.8%. Phathom Pharmaceuticals, Inc. accounts for 77.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $20,987 and has fallen 74.6% since, to $5,332 in 2025.

$28,543in general payments, 2019–2025

Across 48 payments — averaging $594.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$22K
  • Braintree Laboratories, Inc.$3K
  • Boston Scientific$2K
  • Pentax Of America, Inc.$368
  • Olympus America Inc.$302
  • Medtronic$102
  • plus $19 from 1 others
$71,523in research payments, 2019–2025

Across 1 payment — averaging $71,523 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Fujifilm Healthcare Americas Corporation$72K

What the payments were for

  • Consulting fees$3,15011%
  • Speaking & faculty fees$20,50072%
  • Travel & lodging$3,14511%
  • Food & beverage$1,3805%
  • Other$3681%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,543 in reported general payments places this provider in the 85th percentile of 374 gastroenterology providers in Missouri.

See all gastroenterology providers in Missouri

Medicare billing

Part B allowed, 2024
$120,892
Medicare patients
548
Services billed
808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab13$87,742
XifaxanRifaximin14$24,830
Mesalamine53$14,042
SutabSod Sulf/Pot Chloride/Mag Sulf40$6,513
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl220$3,451
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates38$2,429
Budesonide DrBudesonide15$1,654
Omeprazole145$1,463
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl71$1,091
Pantoprazole Sodium79$1,075
LoperamideLoperamide Hcl15$590
Famotidine44$525
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg11$213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Braintree Laboratories, Inc.Sutab$3,150$6,51340 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 374 gastroenterology providers in Missouri.

Other gastroenterology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →